Todas as matérias desta categoria, das mais recentes às mais antigas.
Nvidia is expected to set another revenue record when it reports quarterly earnings on Wednesday. Investors are looking for updates on its $1 trillion data-center revenue target. Bloomberg's Caroline Hyde has a preview.
WeTouch Technology (NASDAQ:WETH) reported its unaudited financial results for the first quarter ended March 31, 2026, delivering significant bottom-line acceleration and stable revenue growth.
NextEra Energy (NYSE:NEE) announced Monday a definitive agreement to acquire Dominion Energy (NYSE:D) in an all-stock transaction valued at approximately $67 billion.
Joe Kaiser, the CEO of Switchyard Partners, joined Bloomberg Open Interest to explain why the massive NextEra, Dominion merger is really about powering the AI boom. He breaks down how hyperscale data centers are reshaping the US energy grid, why regulators will likely approve the deal, and why renewable energy plus natural gas will define the next era of AI infrastructure.
NextEra Energy agreed to pay about $67 billion in stock for Dominion Energy in the biggest power acquisition ever. Bloomberg's Emily Forgash reports on "Bloomberg Open Interest."
Ondas Holdings (NASDAQ:ONDS) has signed a definitive agreement to acquire 100% of Omnisys, an Israeli-based developer of advanced, AI-powered Battle Resource Optimization (BRO) software.
Silexion Therapeutics (NASDAQ:SLXN) reported its financial results for the first quarter ended March 31, 2026, alongside corporate updates highlighting the regulatory progression of its lead RNA interference (RNAi) asset, SIL204.
SOL Strategies (NASDAQ:STKE) announced its financial results for the fiscal second quarter ended March 31, 2026, showcasing strong infrastructure scaling across its validation network despite a localized impact from cryptocurrency price swings.
Ryanair CEO Michael O'Leary discusses the 'incredibly high" costs of air travel in the US, the availability of jet fuel in Europe, and the potential for casualties among European airlines from higher oil prices.
Scienture Holdings (NASDAQ:SCNX) reported its financial results for the first quarter ended March 31, 2026, delivering dramatic top-line acceleration and margin optimization alongside key regulatory and pipeline updates.
NervGen Pharma (NASDAQ:NGEN) reported its financial results and operational updates for the first quarter ended March 31, 2026, highlighting clinical milestones for its lead compound and its recent successful transition to a major U.S. exchange.
Elanco Animal Health (NYSE:ELAN) has announced the phased U.S. launch of Befrena (tirnovetmab), a new anti-IL-31 monoclonal antibody (mAb) injectable solution indicated for the treatment of canine allergic and atopic dermatitis.
